You are here

Takeda hikes outlook on cancer drug sales, Q3 profit jumps 60%


TAKEDA Pharmaceutical Co Ltd said that its annual profit will outstrip a prior estimate and reach a six-year high, boosted by stronger sales of the cancer drug Velcade, after earlier reporting better-than-expected quarterly earnings.

Velcade is used to treat multiple myeloma...

Market voices on: